Vivopharm Holding ApS: Financial statements 2024
CVR: 41452935
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Vivopharm Holding ApS (CVR 41452935) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -7,188 and a net result of DKK -8,097 compared with DKK -7,473 the year before. Equity in the 2024 report amounted to DKK -35,251. The company had 1 employee in the financial year.
- Gross Profit
- DKK -7,188
- Profit/Loss
- DKK -8,097
- Equity
- DKK -35,251
- Total Assets
- DKK 0
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -7K | -8K | -35K | 1 |
| 2023 | - | -7K | -7K | -27K | 1 |
| 2022 | - | -7K | -107K | -20K | 1 |
| 2021 | - | -6K | -6K | 88K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Vivopharm Holding ApS has published its annual report for 2023. Gross profit came to DKK -6,863, and the net result was DKK -7,473.
About Vivopharm Holding ApS
Vivopharm Holding ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Gert Mads Bolwig. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -7,131 and a net result of DKK -8,935 compared with DKK -8,097 the year before. Equity in the 2025 report amounted to DKK -44,186.